Performance-Enhancing Drugs: Understanding the Risks

Hatton Caroline K.; Green Gary A.; Ambrose Peter J.

首页> 外文期刊>Physical medicine and rehabilitation clinics of North America >Performance-Enhancing Drugs: Understanding the Risks

【24h】

Performance-Enhancing Drugs: Understanding the Risks

机译：增强性能的药物：了解风险

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

To help clinicians understand the risks associated with performance-enhancing drugs, this overview covers prohibited lists of substances and methods, therapeutic use exemptions, the legitimate indications and adverse effects, including for megadose and polypharmacy doping of stimulants, anabolic steroids, erythropoiesis-stimulating agents, and growth hormone and ways in which physicians or patients risk committing anti-doping rule violations inadvertently.

机译：为了帮助临床医生了解与提高性能的药物有关的风险，此概述涵盖了禁用的物质和方法清单，豁免的治疗用途，合法的适应症和不良反应，包括大剂量和多药兴奋剂，合成代谢类固醇，促红细胞生成素的使用，生长激素以及医师或患者无意中犯有违反反兴奋剂规则的风险。

著录项

来源
《Physical medicine and rehabilitation clinics of North America》 |2014年第4期|共18页
作者
Hatton Caroline K.; Green Gary A.; Ambrose Peter J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类康复医学;
关键词
Anabolic steroids; Blood doping; Dietary supplements; Growth hormone; Nonanalytical positive doping cases; Sports doping; Stimulants; Therapeutic use exemptions;

机译：合成代谢类固醇;血液兴奋剂;膳食补充剂;生长激素;非分析性阳性兴奋剂病例;运动兴奋剂;兴奋剂;治疗性使用豁免;

相似文献

外文文献
中文文献
专利

1. Performance-Enhancing Drugs: Understanding the Risks [J] . Hatton Caroline K., Green Gary A., Ambrose Peter J. Physical medicine and rehabilitation clinics of North America . 2014,第4期

机译：增强性能的药物：了解风险
2. Performance-Enhancing Drugs I: Understanding the Basics of Testing for Banned Substances [J] . Cadwallader Amy B., Murray Bob International journal of sport nutrition and exercise metabolism . 2015,第4期

机译：增强性能的药物I：了解违禁物质测试的基础
3. Drug-eluting stents: patient understanding of the risks of premature cessation of antiplatelet drugs. [J] . Trentman TL, Rosenfeld DM, Danielson DR, Journal of cardiothoracic and vascular anesthesia . 2008,第6期

机译：药物洗脱支架：患者了解抗血小板药物过早停止的风险。
4. Development of a lateral-flow assay for rapid screening of the performance-enhancing sympathomimetic drug clenbuterol used in animal production;food safety assessments [C] . Weihua Lai, Department of Animal Science and Industry, Yang Xu, 国际营养科学联盟第八届临床营养学大会暨第五届亚太临床营养学会大会 . 2006

机译：开发侧向流分析法以快速筛选用于动物生产的性能增强的拟交感神经药克仑特罗;食品安全性评估
5. Body image and willingness to risk health: A comparison between users and non-users of anabolic-androgenic steroids and other appearance/performance-enhancing drugs. [D] . Carr, Sasha J. 2006

机译：身体形象和冒险健康的意愿：合成代谢雄激素类固醇和其他改善外观/功能的药物的使用者与非使用者之间的比较。
6. Understanding the Paths to Appearance- and Performance-Enhancing Drug Use in Bodybuilding [O] . Ronan Coquet, Peggy Roussel, Fabien Ohl -1

机译：了解健美运动中外观和性能增强药物使用的途径
7. Understanding the Paths to Appearance- and Performance-Enhancing Drug Use in Bodybuilding [O] . Ronan Coquet, Peggy Roussel, Fabien Ohl 2018

机译：了解外观和性能增强药物在健美的路径

Performance-Enhancing Drugs: Understanding the Risks

摘要

著录项

相似文献

相关主题

期刊订阅